EP4356911

MIGALASTAT FOR USE IN THE TREATMENT OF FABRY DISEASE IN ERT-NAIVE AND ERT-EXPERIENCED PATIENTS

  • Status:
    EP einkaleyfi: EP einkaleyfi tilnefnt til gildistöku á Íslandi
  • EP appl. date:
    19.7.2017
  • EP published:
    8.4.2026
  • EP application number:
    23219947.1
  • Max expiry date:
    18.7.2037
  • Expiry date:
    7.8.2026
  • Title in English:
    MIGALASTAT FOR USE IN THE TREATMENT OF FABRY DISEASE IN ERT-NAIVE AND ERT-EXPERIENCED PATIENTS
  • Language of the patent:
    English

Timeline

Today
19.7.2017EP application
8.4.2026EP Publication
7.8.2026Expires

Owner

  • Name:
    Amicus Therapeutics, Inc.
  • Address:
    3675 Market Street, Philadelphia, PA 19104, US

Inventor

  • Name:
    Castelli, Jeff
  • Address:
    Cranbury New Jersey, 08512, US

Priority

  • Number:
    201615213920
  • Date:
    19.7.2016
  • Country:
    US

Classification

  • Categories:
    A61K 31/445, A61P 9/00, A61P 3/00, A61P 13/12

Upload documents